AU2002217229A1 - Pharmaceutical dronedarone composition for parenteral administration - Google Patents
Pharmaceutical dronedarone composition for parenteral administrationInfo
- Publication number
- AU2002217229A1 AU2002217229A1 AU2002217229A AU2002217229A AU2002217229A1 AU 2002217229 A1 AU2002217229 A1 AU 2002217229A1 AU 2002217229 A AU2002217229 A AU 2002217229A AU 2002217229 A AU2002217229 A AU 2002217229A AU 2002217229 A1 AU2002217229 A1 AU 2002217229A1
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical
- parenteral administration
- dronedarone
- composition
- dronedarone composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- ZQTNQVWKHCQYLQ-UHFFFAOYSA-N Dronedarone Chemical compound C1=CC(OCCCN(CCCC)CCCC)=CC=C1C(=O)C1=C(CCCC)OC2=CC=C(NS(C)(=O)=O)C=C12 ZQTNQVWKHCQYLQ-UHFFFAOYSA-N 0.000 title 1
- 229960002084 dronedarone Drugs 0.000 title 1
- 238000007911 parenteral administration Methods 0.000 title 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0016071A FR2817750B1 (en) | 2000-12-11 | 2000-12-11 | DRONEDARONE PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION |
| FR00/16071 | 2000-12-11 | ||
| PCT/FR2001/003903 WO2002047660A1 (en) | 2000-12-11 | 2001-12-10 | Pharmaceutical dronedarone composition for parenteral administration |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002217229A1 true AU2002217229A1 (en) | 2002-08-29 |
| AU2002217229B2 AU2002217229B2 (en) | 2006-05-18 |
Family
ID=8857483
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002217229A Ceased AU2002217229B2 (en) | 2000-12-11 | 2001-12-10 | Pharmaceutical dronedarone composition for parenteral administration |
| AU1722902A Pending AU1722902A (en) | 2000-12-11 | 2001-12-10 | Pharmaceutical dronedarone composition for parenteral administration |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU1722902A Pending AU1722902A (en) | 2000-12-11 | 2001-12-10 | Pharmaceutical dronedarone composition for parenteral administration |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6939865B2 (en) |
| EP (1) | EP1343473B1 (en) |
| JP (1) | JP4399161B2 (en) |
| KR (1) | KR100849758B1 (en) |
| CN (1) | CN1235566C (en) |
| AR (1) | AR031649A1 (en) |
| AT (1) | ATE348599T1 (en) |
| AU (2) | AU2002217229B2 (en) |
| BG (1) | BG66187B1 (en) |
| BR (1) | BR0116060B1 (en) |
| CA (1) | CA2427375C (en) |
| CZ (1) | CZ297788B6 (en) |
| DE (1) | DE60125411T2 (en) |
| EA (1) | EA005314B1 (en) |
| FR (1) | FR2817750B1 (en) |
| HK (1) | HK1055906A1 (en) |
| HU (1) | HU229372B1 (en) |
| IL (2) | IL155428A0 (en) |
| IS (1) | IS2349B (en) |
| MA (1) | MA26969A1 (en) |
| ME (2) | MEP20408A (en) |
| MX (1) | MXPA03005221A (en) |
| NO (1) | NO332294B1 (en) |
| NZ (1) | NZ525661A (en) |
| OA (1) | OA12416A (en) |
| PL (1) | PL199846B1 (en) |
| RS (1) | RS50348B (en) |
| SK (1) | SK287115B6 (en) |
| TW (1) | TWI246926B (en) |
| WO (1) | WO2002047660A1 (en) |
| ZA (1) | ZA200303406B (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200800177A (en) * | 2006-02-14 | 2008-01-01 | Wyeth Corp | Aqueous pharmaceutical formulations of ERβ selective ligands |
| GB0719180D0 (en) | 2007-10-02 | 2007-11-14 | Cambrex Karlskoga Ab | New process |
| FR2930149B1 (en) * | 2008-04-17 | 2011-02-18 | Sanofi Aventis | ASSOCIATION OF DRONEDARONE WITH AT LEAST ONE DIURETIC, ITS THERAPEUTIC APPLICATION |
| AR072950A1 (en) | 2008-04-17 | 2010-10-06 | Sanofi Aventis | USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR MORTALITY, PHARMACEUTICAL COMPOSITION, MANUFACTURING ARTICLE AND PACKAGING |
| EP2116239A1 (en) * | 2008-04-29 | 2009-11-11 | Sanofi-Aventis | Method for managing the risks associated with an increase in serum creatinine during dronedarone treatment |
| FR2959132A1 (en) * | 2010-04-22 | 2011-10-28 | Sanofi Aventis | METHODS FOR RISK EVALUATION AND REDUCTION |
| TWI508726B (en) | 2009-12-21 | 2015-11-21 | Gilead Sciences Inc | Method of treating atrial fibrillation |
| US20120005128A1 (en) * | 2010-06-29 | 2012-01-05 | Sanofi | Methods for reducing the risk of an adverse dronedarone / calcium channel blockers interaction in a patient suffering from atrial fibrilation |
| US8602215B2 (en) | 2010-06-30 | 2013-12-10 | Sanofi | Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation |
| CN102342907A (en) | 2010-07-30 | 2012-02-08 | 江苏恒瑞医药股份有限公司 | Dronedarone solid dispersoid and preparation method thereof |
| KR20120094557A (en) * | 2011-02-01 | 2012-08-27 | 동아제약주식회사 | Pharmaceutical composition containing antiarrhythmic drug with ph-independent dissolution property |
| CN102908307A (en) * | 2011-08-03 | 2013-02-06 | 天津市嵩锐医药科技有限公司 | Dronedarone hydrochloride pharmaceutical composition for injection and preparation method thereof |
| SG11201500123XA (en) * | 2012-07-12 | 2015-02-27 | Sanofi Sa | Anti-tumoral composition comprising the compound 1-(6-{[6-(4-fluorophenyl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}-1,3-benzothiazol-2-yl)-3-(2-morpholin-4-ylethyl)urea |
| WO2022083636A1 (en) * | 2020-10-20 | 2022-04-28 | 上海博志研新药物技术有限公司 | Dronedarone hydrochloride pharmaceutical composition, and preparation method therefor and use thereof |
| TW202320751A (en) * | 2021-08-16 | 2023-06-01 | 大陸商上海博志研新藥物技術有限公司 | Dronedarone hydrochloride injection composition, preparation method and application thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4727064A (en) * | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
| FR2746013B1 (en) * | 1996-03-18 | 1998-05-29 | Sanofi Sa | USE OF ANTIARRHYTHMIC COMPOUNDS IN THE PREVENTION OF POST INFARCT MORTALITY |
| JP2004327321A (en) * | 2003-04-25 | 2004-11-18 | Jst Mfg Co Ltd | Connector |
-
2000
- 2000-12-11 FR FR0016071A patent/FR2817750B1/en not_active Expired - Fee Related
-
2001
- 2001-12-10 ME MEP-204/08A patent/MEP20408A/en unknown
- 2001-12-10 AT AT01270322T patent/ATE348599T1/en not_active IP Right Cessation
- 2001-12-10 PL PL362788A patent/PL199846B1/en unknown
- 2001-12-10 SK SK726-2003A patent/SK287115B6/en not_active IP Right Cessation
- 2001-12-10 RS YUP-465/03A patent/RS50348B/en unknown
- 2001-12-10 AU AU2002217229A patent/AU2002217229B2/en not_active Ceased
- 2001-12-10 ZA ZA200303406A patent/ZA200303406B/en unknown
- 2001-12-10 EP EP01270322A patent/EP1343473B1/en not_active Expired - Lifetime
- 2001-12-10 ME MEP-2008-204A patent/ME00083B/en unknown
- 2001-12-10 WO PCT/FR2001/003903 patent/WO2002047660A1/en active IP Right Grant
- 2001-12-10 CA CA2427375A patent/CA2427375C/en not_active Expired - Fee Related
- 2001-12-10 CZ CZ20031612A patent/CZ297788B6/en not_active IP Right Cessation
- 2001-12-10 AR ARP010105716A patent/AR031649A1/en not_active Application Discontinuation
- 2001-12-10 IL IL15542801A patent/IL155428A0/en active IP Right Grant
- 2001-12-10 NZ NZ525661A patent/NZ525661A/en not_active IP Right Cessation
- 2001-12-10 EA EA200300406A patent/EA005314B1/en not_active IP Right Cessation
- 2001-12-10 TW TW090130522A patent/TWI246926B/en not_active IP Right Cessation
- 2001-12-10 AU AU1722902A patent/AU1722902A/en active Pending
- 2001-12-10 BR BRPI0116060-5B1A patent/BR0116060B1/en not_active IP Right Cessation
- 2001-12-10 US US10/450,320 patent/US6939865B2/en not_active Expired - Lifetime
- 2001-12-10 KR KR1020037007744A patent/KR100849758B1/en active IP Right Grant
- 2001-12-10 MX MXPA03005221A patent/MXPA03005221A/en active IP Right Grant
- 2001-12-10 DE DE60125411T patent/DE60125411T2/en not_active Expired - Lifetime
- 2001-12-10 CN CNB018203884A patent/CN1235566C/en not_active Expired - Fee Related
- 2001-12-10 JP JP2002549234A patent/JP4399161B2/en not_active Expired - Fee Related
- 2001-12-10 OA OA1200300152A patent/OA12416A/en unknown
- 2001-12-10 HU HU0500842A patent/HU229372B1/en not_active IP Right Cessation
-
2003
- 2003-04-14 IL IL155428A patent/IL155428A/en not_active IP Right Cessation
- 2003-04-18 BG BG107748A patent/BG66187B1/en unknown
- 2003-04-29 NO NO20031958A patent/NO332294B1/en not_active IP Right Cessation
- 2003-04-30 IS IS6801A patent/IS2349B/en unknown
- 2003-06-03 MA MA27190A patent/MA26969A1/en unknown
- 2003-11-14 HK HK03108327A patent/HK1055906A1/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU781269C (en) | Pharmaceutical compositions | |
| AU2001250420A1 (en) | Pharmaceutical compositions | |
| AU2001274307A1 (en) | Pharmaceutical compositions | |
| AU2331801A (en) | Improved pharmaceutical compositions for poorly soluble drugs | |
| AU3192700A (en) | Medicinal compositions | |
| AU3556400A (en) | Pharmaceutical compositions | |
| AU2005300A (en) | Medicinal compositions | |
| AU2002217229A1 (en) | Pharmaceutical dronedarone composition for parenteral administration | |
| AU1887401A (en) | Medicinal composition | |
| AU1735001A (en) | Cyclodextrin-containing pharmaceutical composition | |
| HK1055906A1 (en) | Pharmaceutical dronedarone composition for parenteral administration | |
| AU2002214324A1 (en) | Medicinal compositions | |
| AU2002221115A1 (en) | Medicinal compositions having improved absorbability | |
| AU2001290239A1 (en) | Medicinal composition | |
| AU4304400A (en) | Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives | |
| AU2001292331A2 (en) | 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation | |
| AU2001292331A1 (en) | 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation | |
| AU2001273919A1 (en) | Pharmaceutical compositions | |
| AU6460400A (en) | Pharmaceutical compositions | |
| AU2002215114A1 (en) | Pharmaceutical compositions for inhalation | |
| AU6460200A (en) | Pharmaceutical compositions | |
| AU4085201A (en) | Pharmaceutical composition | |
| AU6460100A (en) | Pharmaceutical compositions | |
| AU6460300A (en) | Pharmaceutical compositions | |
| AU4914400A (en) | Novel pharmaceutical composition |